Michel Komajda

Active 1990–2023

147
Papers
70,752
Citations
103
h-index
145
i10-index

Citations

Citations per year for Michel Komajda1982: 1 citations1986: 5 citations1991: 1 citations1992: 5 citations1993: 7 citations1994: 14 citations1995: 18 citations1996: 23 citations1997: 43 citations1998: 75 citations1999: 71 citations2000: 50 citations2001: 50 citations2002: 47 citations2003: 78 citations2004: 117 citations2005: 159 citations2006: 225 citations2007: 265 citations2008: 374 citations2009: 544 citations2010: 628 citations2011: 623 citations2012: 668 citations2013: 667 citations2014: 623 citations2015: 568 citations2016: 549 citations2017: 557 citations2018: 428 citations2019: 1,718 citations2020: 1,836 citations2021: 1,946 citations2022: 1,374 citations2023: 864 citations2024: 1,350 citations2025: 568 citations2026: 13 citations1983–1985: no citations, so these years are not shown1987–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,175 citing papers, 17.5% of this breakdownUnited Kingdom: 2,575 citing papers, 8.7% of this breakdownItaly: 2,215 citing papers, 7.5% of this breakdownGermany: 1,702 citing papers, 5.7% of this breakdownNetherlands: 1,374 citing papers, 4.6% of this breakdownChina: 1,237 citing papers, 4.2% of this breakdownCanada: 1,157 citing papers, 3.9% of this breakdownFrance: 1,155 citing papers, 3.9% of this breakdownSpain: 982 citing papers, 3.3% of this breakdownSweden: 919 citing papers, 3.1% of this breakdownAustralia: 878 citing papers, 3% of this breakdownJapan: 767 citing papers, 2.6% of this breakdown
0%17.5%Other 32%

Fields

  • Medicine86.8%
  • Biochemistry, Genetics and Molecular Biology7%
  • Immunology and Microbiology1%
  • Engineering0.9%
  • Neuroscience0.8%
  • Nursing0.7%
  • Other2.8%

Topics

  • Heart Failure Treatment and Management8.9%
  • Cardiovascular Function and Risk Factors7.2%
  • Diabetes Treatment and Management5.6%
  • Blood Pressure and Hypertension Studies4.1%
  • Cardiomyopathy and Myosin Studies3.1%
  • Diabetes, Cardiovascular Risks, and Lipoproteins2.7%
  • Other68.4%

Coauthors

All papers

Open in search
  1. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Colin Baigent, Marianne Brodmann, Héctor Bueno, Claudio Ceconi, Ovidiu Chioncel, Andrew J.S. Coats, Jean-Philippe Collet, Peter W. Collins, Bernard Cosyns, Carlo Di Mario, Miles Fisher, Donna Fitzsimons, Sigrun Halvorsen, Dominique Hansen, Arno W. Hoes, Richard I. G. Holt, Philip Home, Hugo A Katus, Kamlesh Khunti, Michel Komajda, Ekaterini Lambrinou, Ulf Landmesser, Basil S Lewis, Cecilia Linde, Roberto Lorusso, François Mach, Christian Mueller, Franz-Josef Neumann, Frederik Persson, Steffen E Petersen, Anna Sonia Petronio, Dimitrios J Richter, Giuseppe M.C. Rosano, Peter Rossing, Lars Rydén, Е. V. Shlyakhto, Iain A Simpson, Rhian M. Touyz, William Wijns, Matthias Wilhelm, Bryan Williams, Victor Aboyans, Clifford J Bailey, Antonio Ceriello, Victoria Delgado, Massimo Federici, Gerasimos Filippatos, Diederick E Grobbee, Tina Birgitte Hansen, Heikki Huikuri, Isabelle Johansson, Peter Jüni, Maddalena Lettino, Nikolaus Marx, Linda Mellbin, Carl Johan Östgren, Bianca Rocca, Marco Roffi, Naveed Sattar, Petar Seferovic, Miguel Sousa-Uva, Paul Valensi, David C Wheeler, Stephan Windecker, Victor Aboyans, Colin Baigent, Jean-Philippe Collet, Verónica Dean, Victoria Delgado, Donna Fitzsimons and 72 more - European Heart Journal 2019 cited by 4,870

  2. Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 cited by 1,824

  3. Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

    Authors: , , , , , , , , , , - New England Journal of Medicine 2008 cited by 1,947

  4. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2016 cited by 1,084

  5. Effects of Torcetrapib in Patients at High Risk for Coronary Events

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2007 cited by 3,144

  6. Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aldo P. Maggioni, Frank Ruschitzka, John J.V. McMurray - European Journal of Heart Failure 2018 cited by 716

  7. Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , - Circulation 2020 cited by 424

  8. Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial

    Authors: , , , , , , , , , , , , , , , , , , - Circulation 2021 cited by 343

  9. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

    Authors: , , , , , , , - The Lancet 2010 cited by 2,554

  10. 2013 ESH/ESC Guidelines for the management of arterial hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Margus Viigimaa, Ettore Ambrosioni, Mark Caufield, António Coca, Michael Hecht Olsen, Roland E Schmieder, Costas Tsioufis, Philippe van de Borne, Jose Luis Zamorano, Stephan Achenbach, Helmut Baumgartner, Jeroen J. Bax, Héctor Bueno, Veronica Dean, Christi Deaton, Çetin Erol, Robert Fagard, Roberto Ferrari, David Hasdai, Arno W Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Patrizio Lancellotti, Aleš Linhart, Petros Nihoyannopoulos, Massimo Piepoli, Piotr Ponikowski, Per Anton Sirnes, Juan Tamargo, Michał Tendera, Adam Torbicki, William Wijns, Stephan Windecker, Denis Clément, António Coca, Thierry Gillebert, Michał Tendera, Enrico Agabiti Rosei, Ettore Ambrosioni, Stefan D Anker, Johann Bauersachs, Jana Brguljan Hitij, Mark J. Caulfield, Marc De Buyzere, Sabina De Geest, Geneviève Dérumeaux, Serap Erdine, Csaba Farsang, Christian Funck‐Brentano, Vjekoslav Gerc, Giuseppe Germanò, Stephan Gielen, Herman Haller, Arno W Hoes, Jens Jordan, Thomas Kahan, Michel Komajda, Dragan Lović, Heiko Mahrholdt, Michael Hecht Olsen, Jan Östergren, Gianfranco Parati, Joep Perk, Jorge Polónia, Bogdan A Popescu, Zeljko Reiner, Lars Rydén, Yu.M. Sіrenko, Alice Stanton and 6 more - European Heart Journal 2013 cited by 13,677

  11. Rosuvastatin in Older Patients with Systolic Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2007 cited by 1,493

  12. Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2019 cited by 162

  13. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

    Authors: , , , , , , , , - The Lancet 2009 cited by 1,397

  14. Atlas of the clinical genetics of human dilated cardiomyopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alessandra Serio, Maurizia Grasso, Petros Syrris, Eleanor Wicks, Vincent Plagnol, Luís R. Lopes, Tenna Gadgaard, Hans Eiskjær, Mads Emil Jørgensen, Diego García-Giustiniani, Martín Ortiz-Genga, María G. Crespo‐Leiro, Rondal H. Lekanne Dit Deprez, Imke Christiaans, Ingrid A van Rijsingen, Arthur A. Wilde, Anders Waldenström, Martino Bolognesi, Riccardo Bellazzi, Stellan Mörner, Justo Lorenzo Bermejo, Lorenzo Monserrat, Eric Villard, Jens Mogensen, Yigal M. Pinto, Philippe Charron, Perry Elliott, Eloisa Arbustini, Hugo A. Katus, Benjamin Meder - European Heart Journal 2014 cited by 568

  15. Hypertrophic Cardiomyopathy

    Authors: , , , , , , , , , , , , , , , - Circulation 2003 cited by 1,276

  16. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

    Authors: , , , , , , , - The Lancet 2010 cited by 1,102

  17. Sex-Related Differences in Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , - Circulation Heart Failure 2019 cited by 135

  18. Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , G. Michael Felker, Gregg C. Fonarow, Daniel Gennevois, Stephen S. Gottlieb, James A. Hill, Judd E. Hollander, Jonathan G. Howlett, Michael Hudson, Robb D. Kociol, Henry Krum, Aleksandras Laucevičius, Wayne C. Levy, Gustavo Méndez, Marco Metra, Sanjay Mittal, Byung‐Hee Oh, Naveen L. Pereira, Piotr Ponikowski, W.H. Wilson Tang, Supachai Tanomsup, John R. Teerlink, F. Triposkiadis, Richard W. Troughton, Adriaan A. Voors, David J. Whellan, Faı̈ez Zannad, Robert M. Califf - New England Journal of Medicine 2011 cited by 1,235

  19. Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

    Authors: , , , , , , , , , , - The Lancet 2009 cited by 645

  20. Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events

    Authors: , , , , , , , , , , , , , , , , , , , , , - JACC Heart Failure 2023 cited by 46

  21. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , José Luís Zamorano, Document Reviewers, Michał Tendera, A. Auricchio, J BAX, Michael Böhm, Ugo Corrà, Paolo Della Bella, Perry Elliott, Ferenc Folláth, Mihai Gheorghiade, Yonathan Hasin, Anders Hernborg, Tiny Jaarsma, Michel Komajda, Ran Kornowski, Massimo Piepoli, Bernard Prendergast, Luigi Tavazzi, J.-L. Vachiéry, Freek W.A. Verheugt, José Luís Zamorano, F. Zannad - European Heart Journal 2008 cited by 2,695

  22. Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction

    Authors: , , , , , , , , - Circulation 2011 cited by 514

  23. Characterization of Subgroups of Heart Failure Patients with Preserved Ejection Fraction with Possible Implications for Prognosis and Treatment Response

    Authors: , , , , , , , , , - European Journal of Heart Failure 2015 cited by 282

  24. Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients With Heart Failure and Preserved Ejection Fraction

    Authors: , , , , , , , , , , - Circulation Heart Failure 2012 cited by 219